Go CC, Annie F, Drabish K, Eslami MH, et al. GLP-1 receptor agonists are associated with fewer major adverse cardiovascular and limb events in patients with moderate PAD. J Vasc Surg 2025 May 24:S0741-5214(25)01112-7. doi: 10.1016/j.jvs.2025.
PMID: 40484062